Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins

Aspirin Intake and Survival After Breast Cancer

(2010) Michelle D. Holmes et al.   JOURNAL OF CLINICAL ONCOLOGY

New Studies Support Case for Bisphosphonates as Possible Chemopreventive Agent

(2010) C. Schmidt   JNCI-Journal of the National Cancer Institute

Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma

(2009) Andréia Hanada Otake et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

(2009) E.R. Koomen et al.   Cancer Epidemiology

Reduced Risk of Bone Metastasis for Patients With Breast Cancer Who Use COX-2 Inhibitors

(2009) Matias E. Valsecchi et al.   Clinical Breast Cancer

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

(2009) Stefan Wilop et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Angiotensin inhibition and malignancies: a review

(2009) T Rosenthal et al.   JOURNAL OF HUMAN HYPERTENSION

Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials

(2009) Craig I Coleman et al.   JOURNAL OF HYPERTENSION

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

(2009) Michael Gnant et al.   NEW ENGLAND JOURNAL OF MEDICINE

AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist

(2009) D. R. Rhodes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression

(2008) Yuichiro Ohnuma et al.   BIOMEDICINE & PHARMACOTHERAPY

Estrogen Receptor-Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users

(2008) A. S. Kumar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Association of ACE Inhibitors and Angiotensin Receptor Blockers with Keratinocyte Cancer Prevention in the Randomized VATTC Trial

(2008) J. B. Christian et al.   JNCI-Journal of the National Cancer Institute

Simvastatin induces apoptosis in human breast cancer cells in a NFκB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa

(2007) Mikael Åberg et al.   THROMBOSIS RESEARCH